Cargando…
Barbigerone Potentially Alleviates Rotenone-Activated Parkinson’s Disease in a Rodent Model by Reducing Oxidative Stress and Neuroinflammatory Cytokines
[Image: see text] Background: Parkinson’s disease (PD) is a common age-related and slowly progressive neurodegenerative disease that affects approximately 1% of the elderly population. In recent years, phytocomponents have aroused considerable interest in the research for PD treatment as they provid...
Autores principales: | Alharthy, Khalid M., Althurwi, Hassan N., Albaqami, Faisal F., Altharawi, Ali, Alzarea, Sami I., Al-Abbasi, Fahad A., Nadeem, Muhammad Shahid, Kazmi, Imran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910078/ https://www.ncbi.nlm.nih.gov/pubmed/36777578 http://dx.doi.org/10.1021/acsomega.2c05837 |
Ejemplares similares
-
Europinidin Inhibits Rotenone-Activated Parkinson’s Disease in Rodents by Decreasing Lipid Peroxidation and Inflammatory Cytokines Pathways
por: Altharawi, Ali, et al.
Publicado: (2022) -
Barbigerone prevents scopolamine-induced memory impairment in rats by inhibiting oxidative stress and acetylcholinesterase levels
por: AlGhamdi, Shareefa A., et al.
Publicado: (2023) -
Computational Modeling and Evaluation of Potential mRNA and Peptide-Based Vaccine against Marburg Virus (MARV) to Provide Immune Protection against Hemorrhagic Fever
por: Albaqami, Faisal F., et al.
Publicado: (2023) -
Development of a Novel Vaccine Candidates against Cardiobacterium valvarum through Reverse Vaccinology and Computational Approaches
por: Albaqami, Faisal F., et al.
Publicado: (2023) -
Rosinidin inhibits NF-κB/ Nrf2/caspase-3 expression and restores neurotransmitter levels in rotenone-activated Parkinson's disease
por: Alghamdi, Amira M., et al.
Publicado: (2023)